The number of people using GLP-1 treatments like Ozempic and Wegovy for weight loss or chronic conditions has increased rapidly, with more than 1 in 10 U.S. adults currently taking such medications. A new study led by medical ...
8 hours ago
0
4
New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, found no link between semaglutide use and pancreatic cancer in nationwide registry ...
3 hours ago
0
0
New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, makes a case for extending the indication for GLP-1 receptor agonists (GLP1-RAs) ...
Sep 27, 2026
0
15
New analyses to be presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, show that orforglipron, a daily oral medication for weight loss and type 2 ...
Sep 26, 2026
0
125
Smartwatches have become an increasingly popular way for people to monitor their health and fitness. About 100 million—nearly 4 in 10—U.S. adults own a smartwatch. Worldwide, market research estimates approximately 560 million ...
Sep 26, 2026
0
23
When the body's temperature falls, it adapts by burning more energy to generate heat and triggering appetite to replace the fuel used to stay warm. While scientists have known about those responses for decades, precisely ...
Sep 25, 2026
0
57
Underweight patients are more likely to die after emergency general surgery than patients who are normal weight or overweight, and patients who are both frail and underweight face an even higher risk of death and other adverse ...
Sep 25, 2026
0
6
At least a quarter of Americans have high levels of cholesterol or fatty acids in their blood, a condition called dyslipidemia. Uncontrolled cholesterol levels increase the risk of atherosclerotic cardiovascular disease, ...
Sep 24, 2026
0
12
A person's body size or type, and how well it conforms with society's expectations, can be a source of stress in many cultures. University of Mississippi psychologists examined how people's experiences and perceptions of ...
Sep 24, 2026
0
6
People taking popular GLP-1 medications such as Ozempic, Wegovy and Zepbound may face stigma from those closest to them, according to a new study by a Florida State University professor.
Sep 24, 2026
0
6
